Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Sale of BioZone (Details)

v3.7.0.1
Note 4 - Sale of BioZone (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Note 4 - Sale Of Biozone Details        
Cash proceeds from sale     $ 0 $ 5,942
Consideration for common stock transferred $ 50   50  
Prepaid inventory 2,000   2,000  
Fair market value of the common stock transferred (640)   (640)  
Assets sold:        
Accounts receivable, net (923)   (923)  
Inventory, net (1,761)   (1,761)  
Fixed assets, net (2,003)   (2,003)  
Intangible assets, net (5,657)   (5,657)  
All other assets (41)   (41)  
Liabilities transferred 1,197   1,197  
Transaction and other costs (279)   $ (279)  
Loss on sale of subsidiary $ 0 $ (2,115)   $ (2,115)